Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Proteomics: Biomedical and Pharmaceutical Applications -

Proteomics: Biomedical and Pharmaceutical Applications

Hubert Hondermarck (Herausgeber)

Buch | Hardcover
396 Seiten
2004 | 2004 ed.
Springer-Verlag New York Inc.
978-1-4020-2322-4 (ISBN)
CHF 279,95 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
Proteins are the functional output of genes and there are two main outcomes from human proteomics. The first is to discover molecular markers for early diagnosis and profiling of pathologies. The second is to decipher the intracellular signaling pathways. This book explores the challenge through a series of projects.
Human biology has now entered into a phase of post-genomics and it might not be an exaggeration to say that the major outcome of the human genome sequencing has finally been to open the way to the exploration of the proteome-proteomics.


Proteins are the functional output of genes and there are two main expected outcomes from human proteomics. The first is to discover new molecular markers for early diagnosis and profiling of pathologies. The second is to decipher the intracellular signaling pathways leading to the initiation and progression of pathologies, for the identification of new targets and the development of innovative therapeutic strategies. This is clearly a promising challenge that this book explores through a series of ongoing experiences and projects representative of the new era in which biology and medicine have now entered.

Preface. List of contributors. 1. Proteomics Today, Proteomics Tomorrow; R.A. Bradshaw. 2. Proteomic Technologies and Application to the Study of Heart Disease; E. McGregor, M.J. Dunn. 3. Proteomics : Haematological Perspectives; J.D. Tissot, P. Schneider. 4. Proteomics in the Neurosciences; M.O. Collins, H. Husi, S.G.N. Grant. 5. Ocular Proteomics; M. Faupel, E. Bertrand, J.V. Oostrum. 6. Proteomics in Oncology : the Breast Cancer Experience; F. Vandermoere, Ikram El Yazidi-Belkoura, Eric Adriaenssens, J. Lemoine, H. Hondermarck. 7. Proteomics of Hepatocellular Carcinoma: Present Status and Future Prospects; M.C.M. Chung, R.C.M.Y. Liang, T.K. Seow, J.C.H. Neo, S.L. Lo, G.S. Tan. 8. Proteomics and Peptidomics of Gestational Disease; N.M. Page. 9. Applications of Proteomics Technologies for Drug Discovery; K.K. Jain. 10. Proteomics and Adverse Drug Reactions; M.R. Wilkins. 11. Proteomics for Development of Immunotherapies; J.F. Haeuw, A. Beck. 12. Role of Proteomics in Medical Microbiology; P. Cash. 13. The Immunoproteome of H. pylori; T. Aebischer, A. Krah, D. Bumann, P.R. Jungblut, T.F. Meyer. 14. Proteomics of HIV-1 Virion; S. Misumi, N. Takamune, S. Shoji. 15. Proteomics to Explore Pathogenesis and Drug Resistance Mechanisms in Protozoan Parasites; B. Papadopoulou, J. Drummelsmith, M. Ouellette. Authors index. Subject Index.

Erscheint lt. Verlag 10.8.2004
Zusatzinfo XII, 396 p.
Verlagsort New York, NY
Sprache englisch
Maße 155 x 235 mm
Gewicht 1650 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Biomedizin
Medizin / Pharmazie Studium
Naturwissenschaften Biologie Biochemie
ISBN-10 1-4020-2322-7 / 1402023227
ISBN-13 978-1-4020-2322-4 / 9781402023224
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Entstehung, Progression und Therapie von Krebs

von Christoph Wagener; Oliver Müller

Buch (2022)
Thieme (Verlag)
CHF 279,95
Finding Meaning in a Genome

von Danny E. Miller; Angela L. Miller; R. Scott Hawley

Buch | Softcover (2023)
John Wiley & Sons Inc (Verlag)
CHF 128,65